Publications by authors named "Marc Alcoverro-Bertran"

Transcription factors (TFs) control specificity and activity of gene transcription, but whether a relationship between these two features exists is unclear. Here we provide evidence for an evolutionary trade-off between the activity and specificity in human TFs encoded as submaximal dispersion of aromatic residues in their intrinsically disordered protein regions. We identified approximately 500 human TFs that encode short periodic blocks of aromatic residues in their intrinsically disordered regions, resembling imperfect prion-like sequences.

View Article and Find Full Text PDF

Cell identity is orchestrated through an interplay between transcription factor (TF) action and genome architecture. The mechanisms used by TFs to shape three-dimensional (3D) genome organization remain incompletely understood. Here we present evidence that the lineage-instructive TF CEBPA drives extensive chromatin compartment switching and promotes the formation of long-range chromatin hubs during induced B cell-to-macrophage transdifferentiation.

View Article and Find Full Text PDF

Cell therapy approaches hold great potential for treating retinopathies, which are currently incurable. This study addresses the problem of inadequate migration and integration of transplanted cells into the host retina. To this end, we have identified the chemokines that were most upregulated during retinal degeneration and that could chemoattract mesenchymal stem cells (MSCs).

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Marc Alcoverro-Bertran"

  • - Marc Alcoverro-Bertran's research primarily investigates the mechanisms underlying gene transcription regulation through transcription factors, focusing on the evolutionary trade-offs between their activity and specificity.
  • - His studies demonstrate how specific transcription factors, such as CEBPA, influence three-dimensional genome architecture, thereby shaping cell identity during transdifferentiation processes.
  • - Alcoverro-Bertran also explores novel therapeutic avenues for retinal degeneration by enhancing the migration of mesenchymal stem cells through chemokine receptor signaling, addressing challenges in cell integration for regenerative therapies.